Lung Cancer
Volume 56, Issue 2 , Pages 175-184 , May 2007

Chromosomal aberrations and gene expression profiles in non-small cell lung cancer

  • E. Dehan

      Affiliations

    • Sackler School of Medicine, Tel-Aviv University, Israel
    • ,
  • A. Ben-Dor

      Affiliations

    • Agilent Laboratories, Palo Alto, CA, United States
    • ,
  • W. Liao

      Affiliations

    • NHGRI, NIH, Bethesda, MD, United States
    • ,
  • D. Lipson

      Affiliations

    • Technion, Israel Institute of Technology, Haifa, Israel
    • ,
  • H. Frimer

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • S. Rienstein

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • D. Simansky

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • M. Krupsky

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • P. Yaron

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • E. Friedman

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • G. Rechavi

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • M. Perlman

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • A. Aviram-Goldring

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • S. Izraeli

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • M. Bittner

      Affiliations

    • NHGRI, NIH, Bethesda, MD, United States
    • ,
  • Z. Yakhini

      Affiliations

    • Agilent Laboratories, Palo Alto, CA, United States
    • Technion, Israel Institute of Technology, Haifa, Israel
    • ,
  • N. Kaminski

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
    • Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy and Critical Care Medicine and University of Pittsburgh Cancer Institute, University of Pittsburgh, NW 628 MUH, 3459 5th Avenue, Pittsburgh, PA 15261, United States
    • Corresponding Author InformationCorresponding author at: Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy and Critical Care Medicine and University of Pittsburgh Cancer Institute, University of Pittsburgh, NW 628 MUH, 3459 5th Avenue, Pittsburgh, PA 15261, United States. Tel.: +1 412 6473156; fax: +1 412 6477875.

Received 17 January 2006 ,Revised 5 December 2006 ,Accepted 18 December 2006.

References 

  1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl. 8):S4–S66
  2. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene. 2002;21(45):6877–6883
  3. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998;20(2):207–211
  4. Pollack JR, Chou FL, Rees CA, Christian AT, Bedford JS, Brown PO, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Genome Biol. 2002;3(6):[RESEARCH0026]
  5. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet. 2005;37(Suppl.):S11–S17
  6. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA. 2002;99(20):12963–12968
  7. Wilhelm M, Veltman JA, Olshen AB, Jain AN, Moore DH, Presti JC, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res. 2002;62(4):957–960
  8. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A, et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis. 2004;25(8):1345–1357
  9. DeLeeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, et al. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet. 2004;
  10. Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2002;62(13):3636–3640
  11. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002;1(1):49–52
  12. Kaminski N, Krupsky M. Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology. Chest. 2004;125(5 Suppl.):111S–115S
  13. Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med. 2006;355(6):570–580
  14. Daniely M, Aviram A, Adams EF, Buchfelder M, Barkai G, Fahlbusch R, et al. Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. J Clin Endocrinol Metab. 1998;83(5):1801–1805
  15. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 1998;58(22):5009–5013
  16. Erez A, Perelman M, Hewitt SM, Cojacaru G, Goldberg I, Shahar I, et al. Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene. 2004;23(31):5371–5377
  17. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100(14):8407–8411
  18. Kaminski N, Friedman N. Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol. 2002;27(2):125–132
  19. Ben-Dor A, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z. Tissue classification with gene expression profiles. J Comput Biol. 2000;7(3–4):559–583
  20. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA. 2000;97(4):1778–1783
  21. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406(6795):536–540
  22. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 2001;98(24):13790–13795
  23. Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene. 1998;16(24):3151–3157
  24. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000;60(21):6116–6133
  25. Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, Minna JD, et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer. 2006;118(6):1556–1564
  26. Jiang F, Yin Z, Caraway NP, Li R, Katz RL. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia. 2004;6(5):623–635
  27. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60(7):1949–1960
  28. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA. 1995;273(7):558–563
  29. Carboni GL, Gao B, Nishizaki M, Xu K, Minna JD, Roth JA, et al. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene. 2003;22(4):615–626
  30. Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA. 2001;98(24):13954–13959
  31. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 2002;62(9):2715–2720
  32. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA. 2001;98(10):5711–5716
  33. Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, et al. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol. 2001;19(22):4259–4266
  34. Tan DF, Huberman JA, Hyland A, Loewen GM, Brooks JS, Beck AF, et al. MCM2—a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer. 2001;1(1):6
  35. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, et al. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev. 2000;14(14):1741–1749
  36. Bauer A, Chauvet S, Huber O, Usseglio F, Rothbacher U, Aragnol D, et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J. 2000;19(22):6121–6130
  37. Feng Y, Lee N, Fearon ER. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res. 2003;63(24):8726–8734
  38. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003;201(2):204–212
  39. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, et al. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 2004;64(14):4717–4720
  40. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA. 1998;95(25):14717–14722
  41. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res. 2001;7(7):1998–2004
  42. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003;22(46):7218–7221
  43. Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL. Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet. 2005;14(4):475–482
  44. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia. 2004;6(1):7–14
  45. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene. 2004;23(36):6170–6174
  46. Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE, et al. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res. 2005;11(3):1086–1092
  47. Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, et al. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Res. 2006;66(16):7968–7975
  48. Kerkela E, Ala-aho R, Klemi P, Grenman S, Shapiro SD, Kahari VM, et al. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol. 2002;198(2):258–269
  49. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, et al. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA. 2005;102(27):9625–9630
  50. Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 2005;65(13):5561–5570

PII: S0169-5002(06)00668-4

doi: 10.1016/j.lungcan.2006.12.010

Lung Cancer
Volume 56, Issue 2 , Pages 175-184 , May 2007

Article Tools

* Image Usage & Resolution